Østergren et al. conducted a comparative study examining the impact of Luteinizing Hormone-Releasing Hormone (LHRH) agonists and subcapsular orchiectomy on testosterone reduction in men with prostate cancer. Here, GNRH1 is linked to prostate cancer.